• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    MiMedx Group, Inc - Common Stock (NQ:MDXG)

    4.705 -0.125 (-2.59%)
    Delayed Quote Updated: 12:44 PM EDT, Oct 13, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about MiMedx Group, Inc - Common Stock

    < Previous 1 2 3 4 Next >
    News headline image
    MiMedx (MDXG) Q2 2026 Earnings Call Transcript ↗
    Surgical revenue grew 15% as wound care stabilized ahead of $350M Sanara deal. 
    Via The Motley Fool
    Topics Earnings
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    MiMedx Group Q2 Earnings Call Highlights ↗
    MiMedx Group (NASDAQ:MDXG) said it has agreed to acquire Sanara MedTech in a transaction valued at $35 per Sanara share, a deal the company expects to close by the end of 2026. The announcement... 
    Via MarketBeat
    Topics Earnings
    MIMEDX Group (NASDAQ:MDXG) Shares Fall After Q2 Revenue and EPS Slightly Miss Estimates ↗
    Via Chartmill
    MiMedx Group (NASDAQ:MDXG) Posts Disappointing Q1 Results, Stock Tumbles 8% After-Hours ↗
    Via Chartmill
    MIMEDX Group Inc (NASDAQ:MDXG) Stock Dips Despite Strong Earnings Beat ↗
    Via Chartmill
    News headline image
    Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
    From Biotech Insider
    Via GlobeNewswire
    News headline image
    The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
    From World Street Intelligence
    Via GlobeNewswire
    News headline image
    A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus
    Issued on behalf of Conexeu Sciences Inc. 
    From Equity Insider
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For October 29, 2025 ↗
     
    Via Benzinga
    News headline image
    Earnings Scheduled For July 30, 2025 ↗
     
    Via Benzinga
    News headline image
    Earnings Scheduled For April 30, 2025 ↗
     
    Via Benzinga
    News headline image
    A Peek at MiMedx Group's Future Earnings ↗
     
    Via Benzinga
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
    From TELA Bio, Inc.
    Via GlobeNewswire
    What's going on in today's after hours session ↗
    Via Chartmill
    News headline image
    MiMedx (MDXG) Q4 2025 Earnings Call Transcript ↗
    MiMedx (MDXG) Q4 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings
    News headline image
    Earnings Scheduled For February 26, 2025 ↗
     
    Via Benzinga
    News headline image
    MDXG Stock Rises As MiMedx Enters Into Exclusive Distribution Agreement For Three Products ↗
    According to the agreement, Summit Products Group will distribute Hydrelix, NovaForm, and G4Derm Plus, designed to complement MiMedx’s portfolio of leading surgical and wound products. 
    Via Stocktwits
    Topics Artificial Intelligence
    News headline image
    What's going on in today's after hours session ↗
    As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
    Via Chartmill
    News headline image
    MiMedx (MDXG) Q3 2025 Earnings Call Transcript ↗
    MiMedx (MDXG) Q3 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings
    News headline image
    MIMEDX GROUP INC (NASDAQ:MDXG) Reports Record Q2 2025 Earnings, Surpassing Estimates and Driving Stock Surge ↗
    MIMEDX Group (MDXG) reports record Q2 2025 earnings, beating revenue and EPS estimates with $98.61M in sales and $0.10 EPS. Stock surges 11.8% post-announcement. 
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    Wednesday's after hours session: top gainers and losers ↗
    Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
    Via Chartmill
    News headline image
    Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Why Trade Desk Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    Get insights into the top gainers and losers of Monday's after-hours session. ↗
    Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
     
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.